Recent advances in antenatal diagnosis by amniotic fluid analysis.
D000014:Abnormalities, Drug-Induced / Q000175:diagnosis; D000307:Adrenal Gland Diseases / Q000151:congenital; D000650:Amnion; D000653:Amniotic Fluid / Q000032:analysis* / Q000201:enzymology; D001789:Blood Group Antigens; D002239:Carbohydrate Metabolism, Inborn Errors / Q000175:diagnosis; D002901:Chromosomes, Human, 13-15; D002902:Chromosomes, Human, 16-18; D003933:Diagnosis; D004314:Down Syndrome / Q000175:diagnosis; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D005333:Fetus; D030342:Genetic Diseases, Inborn / Q000517:prevention & control; D005865:Gestational Age; D006801:Humans; D008238:Lysergic Acid Diethylamide; D008297:Male; D008661:Metabolism, Inborn Errors / Q000175:diagnosis; D008722:Methods; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis; D011677:Punctures; D012732:Sex Determination Analysis; D014314:Trisomy; D014777:Virus Diseases / Q000175:diagnosis
D001789:Blood Group Antigens; D008238:Lysergic Acid Diethylamide